PRO-DEX, INC. Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price
PRO-DEX, INC. (PDEX) had Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price of $2.00 per share as of 2017-03-31, per its 10-Q filed 2017-05-11.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1 · last filed 2017-05-11
- 2017-03-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $2.00.
- 2016-12-31: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $2.00.
- 2016-09-30: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $2.01.
- 2016-06-30: Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price $1.95.
| Period end | Share-based Payment Arrangement, Option, Exercise Price Range, Exercisable, Weighted Average Exercise Price |
|---|---|
| 2017-03-31 | $2.00 10-Q · filed 2017-05-11 |
| 2016-12-31 | $2.00 10-Q · filed 2017-02-09 |
| 2016-09-30 | $2.01 10-Q · filed 2016-11-10 |
| 2016-06-30 | $1.95 10-K · filed 2016-09-15 |
| 2016-03-31 | $1.95 10-Q · filed 2016-05-12 |
| 2015-12-31 | $2.43 10-Q · filed 2016-02-11 |
| 2015-09-30 | $2.41 10-Q · filed 2015-11-10 |
| 2015-06-30 | $2.44 10-K · filed 2015-09-17 |
| 2015-03-31 | $2.44 10-Q · filed 2015-05-14 |
| 2014-12-31 | $2.26 10-Q · filed 2015-02-10 |
| 2014-09-30 | $2.26 10-Q · filed 2014-11-13 |
| 2014-06-30 | $2.49 10-K · filed 2014-09-18 |
| 2014-03-31 | $2.55 10-Q · filed 2014-05-12 |
| 2013-12-31 | $2.53 10-Q · filed 2014-02-06 |
| 2013-09-30 | $2.57 10-Q · filed 2013-11-13 |
| 2013-06-30 | $2.61 10-K · filed 2013-09-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Profound Medical Corp. (PROF) | $0.206B | -7.37 | |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |